Work

Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Heart Journal

DOI: 10.1093/eurheartj/ehq374

Authors: Robert S. Rosenson, Michael Elliott, Yuri Stasiv, Colin Hislop, for the PLASMA II Investigators, M. Imburgia, R. Weiss, P. Underwood, D. Ende, C. Brown, V. Nadar, R. Carlson, T. Carlson, D. Wombolt, F. Matar, P. Rossi, F. Eder, D. Hotchkiss

Institutions: Icahn School of Medicine at Mount Sinai, Anthera Pharmaceuticals (United States)

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2032374475

FWCI: 8.432

Cites: 30

Cited by: 67

Related to: 10